Reuse Premarket Guidance Calls For Close Collaboration Between ODE and OC
This article was originally published in The Gray Sheet
Executive Summary
CDRH will rely on quality system inspections, rather than premarket submissions, to review reprocessors' quality control procedures for evaluating incoming products, according to a May 24 guidance on single-use device (SUD) reuse.
You may also be interested in...
General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA
Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.